Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.
Magnet Biomedicine has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in September 2023.
Magnet Biomedicine's investors include ARCH Venture Partners, Newpath Management.
Magnet Biomedicine is headquartered in Cambridge, United States.
Magnet Biomedicine is a biotechnology research platform specializing in discovering true molecular glues.
Magnet Biomedicine is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnet Biomedicine — Funding & Investors." VCBacked, September 19, 2023, https://www.vcbacked.co/company/magnet-biomedicine. Accessed August 14, 2026.
VCBacked. (2023). Magnet Biomedicine — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/magnet-biomedicine
{{cite web |title=Magnet Biomedicine — Funding & Investors |url=https://www.vcbacked.co/company/magnet-biomedicine |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated